Armata Pharmaceuticals

Armata Pharmaceuticals(ARMP)

LOS ANGELES, CA
Pharmaceutical
WebsiteLinkedInCareers Page

Focus: Natural and synthetic bacteriophage-based therapies

Armata Pharmaceuticals is a life sciences company focused on Natural and synthetic bacteriophage-based therapies.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

AB-SA01
Various
N/A
Clinical Trials (1)
NCT03395769Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic
N/A
AB-PA01
Various
N/A
Clinical Trials (1)
NCT03395743Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic
N/A
Phase 1
Clinical Trials (1)
NCT02757755Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults
Phase 1
AP-SA02
Bacteremia
Phase 1/2
Clinical Trials (1)
NCT05184764Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT04596319Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
Phase 1/2
Phase 2
Clinical Trials (1)
NCT05616221Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
Phase 2
Phase 2
Clinical Trials (1)
NCT02509845Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
Phase 2
C16G2 Rinse
Dental Caries
Phase 2
Clinical Trials (1)
NCT02044081Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults
Phase 2
C16G2 Strip
Dental Caries
Phase 2
Clinical Trials (1)
NCT03052842A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
Phase 2
Phase 2
Clinical Trials (1)
NCT02254993Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses
Phase 2
C16G2 Varnish
Dental Caries
Phase 2
Clinical Trials (1)
NCT03004365A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
Phase 2
Phase 2
Clinical Trials (1)
NCT03196219A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects
Phase 2
C16G2 Gel
Dental Caries
Phase 2
Clinical Trials (1)
NCT02594254Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 13 clinical trials
SEC Filings: 2 available

Financials (FY2024)

R&D Spend
$34M4%
Net Income
-$69M
Cash
$14M
Source: SEC 10-K Filing